To include your compound in the COVID-19 Resource Center, submit it here.

Engineered hematopoietic stem and progenitor cells for mucopolysaccharidosis type I

DISEASE CATEGORY: Endocrine/Metabolic

INDICATION: Mucopolysaccharidosis

Hematopoietic stem and progenitor cells (HSPCs) engineered to overexpress IDUA could treat mucopolysaccharidosis

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE